Thermo Fisher Scientific, headquartered in Massachusetts, announced that it will open a new bioanalytical laboratory in GoCo Health Innovation City, located in Gothenburg, Sweden. The new building, situated adjacent to AstraZeneca‘s key research location, will improve the company’s laboratory services.
The new 2694sqm facility is scheduled to open in the fourth quarter of 2025 and will provide advanced bioanalytical capabilities to pharmaceutical and biotechnology clients.
Go deeper with GlobalData
The new lab will have advanced instrumentation and provide bioanalytical services, including technologies, for small and large molecules, biomarkers, and novel modalities. Services include cell-based assays, chromatography, molecular genomics, immunochemistry, flow cytometry and chromatography.
Leon Wyszkowski, president of analytical services for Thermo Fisher Scientific, said that, “We are thrilled to expand our bioanalytical footprint in Europe. Our presence in Sweden will support our customers with accurate and timely data, empowering them to make informed decisions.”
The new lab will create up to 140 new jobs, ranging from entry-level to managerial roles. It is expected to be operational by the end of 2025 and will provide GLP-compliant bioanalytical services for all phases of drug development.
How well do you really know your competitors?
Access the most comprehensive Company Profiles on the market, powered by GlobalData. Save hours of research. Gain competitive edge.
Thank you!
Your download email will arrive shortly
Not ready to buy yet? Download a free sample
We are confident about the unique quality of our Company Profiles. However, we want you to make the most beneficial decision for your business, so we offer a free sample that you can download by submitting the below form
By GlobalData
